about
Assessing Risk and Preventing 30-Day Readmissions in Decompensated Heart Failure: Opportunity to Intervene?Recoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recyclingRole of Imaging Techniques for Diagnosis, Prognosis and Management of Heart Failure Patients: Cardiac Magnetic Resonance.Pharmacologic management of chronic reno-cardiac syndromePharmacogenetics in chronic heart failure: new developments and current challengesNeuregulin as a heart failure therapy and mediator of reverse remodelingUnderstanding the epidemic of heart failure: past, present, and futureNew treatment options for late Na current, arrhythmias, and diastolic dysfunctionArrhythmia risk associated with sleep disordered breathing in chronic heart failureSleep apnea, heart failure, and pulmonary hypertensionCardiometabolic Syndrome and Increased Risk of Heart FailureSleep-Disordered Breathing-Do We Have to Change Gears in Heart Failure?Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?ST2: a novel remodeling biomarker in acute and chronic heart failureHeart failure and tachycardia-induced cardiomyopathyTailoring of self-management interventions in patients with heart failureAddressing the Heterogeneity of Heart Failure in Future Randomized Trials.Global Variations in Patient Populations and Outcomes in Heart Failure Clinical Trials.Burden of Heart Failure in Adults with Congenital Heart Disease.Role of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts.The situation of caregivers in heart failure and their role in improving patient outcomes.Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.Regulation of Cardiomyocyte T-Tubular Structure: Opportunities for Therapy.Surgical therapy for mitral regurgitation: the key to preventing heart failure?Relaxin: review of biology and potential role in treating heart failure.Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.Racial disparities and the use of technology for self-management in blacks with heart failure: a literature reviewROSE-AHF and lessons learned.Does contractility modulation have a role in the treatment of heart failure?Chemotherapy-induced cardiotoxicity.Mechanical circulatory support as a bridge to transplant or for destination therapy.Novel drugs targeting transthyretin amyloidosis.Oral sodium and potassium binders in heart failure.Autoantibodies and cardiovascular dysfunction: cause or consequence?Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumabPulmonary hypertension secondary to left ventricular systolic dysfunction: contemporary diagnosis and managementImpedance cardiography: more questions than answers.Role of physical training in heart failure with preserved ejection fractionUtilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?
P1433
Q26796380-AB3E9079-2AC7-4ECB-B419-E3EFDF86655EQ26822833-B9141944-40C0-44AA-8045-5315361A248BQ26829719-AA3B83DC-0FDB-4F93-BC03-7189EADBFA12Q26829812-CC596B29-E45D-4E1C-9036-A044A535A924Q26852239-66572549-94DA-452F-8016-892DD2E7CD0CQ26991903-5366BEC9-91FF-4933-90B5-471C8186FE58Q26996486-48F7F861-4E02-426A-83D5-AE01568BA4B1Q27012532-7DD96EF5-489A-463C-BA99-A86F8AB59F28Q27012633-B555C16A-2F64-44CF-B8CD-5A3BEEC37F8CQ27026754-4091593D-A9CA-4E71-A18E-281D22CBC46EQ28070075-1DD00DA0-6AC5-47AB-B0BC-6D6EBB2B51D5Q28073906-AF66898E-4E4A-4C18-B482-558D96C4CA81Q28088361-8B50B211-AE17-4F40-9CFD-35669798A10FQ28280799-9D896960-B9EE-4848-899A-3D4EA937F789Q28296989-BB386E65-8999-4B48-9A2B-B3E0A893726EQ28393588-BD26C966-48F4-46A6-A061-8965D5E8DD1AQ30234708-6F43D6FE-FBA4-4106-B20E-3AC05E07172DQ30235985-70CF41FA-8C5D-48BE-8227-34353A0DB00BQ30244374-E2522D61-FB86-456E-8BD7-DB68C0663739Q30575578-0C47EDB3-CAC5-4023-A5D5-99C3A351F4AEQ30655402-AB593CFE-7CBA-4E87-8375-543ECD3086EAQ31046062-4CFE5D45-09A8-4F0A-A0C0-CA7D0541604DQ33653885-8C64729D-20C4-49A4-A0EA-D6C1C4268E10Q33775777-F4F05FF3-C0A9-4C4B-9CA4-AE384F021831Q33873275-5DF0E0E2-90E1-4922-BA3F-91113FA40D9BQ33892283-C507F882-B2D7-4248-983C-58796491DACAQ33984969-DD801039-7473-42FF-AD32-F44CD57EE109Q34117741-E9BE89FD-3511-4C88-88BB-6DA3B5441F4CQ34191160-862ED1A2-252B-461F-BE75-8E43FBACC832Q34258080-7D8CAE8C-6EB4-4D38-A611-1B1AFB4C474CQ34268754-2EA1C106-B762-4393-8D8A-FE03D6C1B08AQ34400138-F29165AA-8B23-462D-A516-B2D96FD21AB7Q34455761-AD075BBE-B877-4407-B7BC-4F2FE2F48226Q34473885-32F5A018-A8DC-436F-875B-6003655B68F2Q34474264-2C6769D5-5C09-40BD-837F-6037FF369FC7Q34525179-7E3A31C3-2626-4F80-9BBB-914533FC1AFEQ34557987-9BC0F273-C736-4D8C-B4B5-658043FDB1D9Q35556222-CAF4E708-E9A2-4441-82AB-5F366FB29500Q35588736-E41B8E67-457B-4D96-8EE5-B72E9D250474Q35761448-ED83350D-4891-4B5A-B70F-9CD89A178C82
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
name
Current heart failure reports
@ast
Current heart failure reports
@en
Current heart failure reports
@es
Current heart failure reports
@it
Current heart failure reports
@nl
type
label
Current heart failure reports
@ast
Current heart failure reports
@en
Current heart failure reports
@es
Current heart failure reports
@it
Current heart failure reports
@nl
prefLabel
Current heart failure reports
@ast
Current heart failure reports
@en
Current heart failure reports
@es
Current heart failure reports
@it
Current heart failure reports
@nl
P3181
P1055
P1156
4000148301
P1476
Current heart failure reports
@en